Document Type : CASE REPORT
Authors
1 Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 https://www.advbiores.net/article.asp?issn=2277-9175;year=2018;volume=7;issue=1;spage=33;epage=33;aulast=Mostofizadeh#:~:text=Department%20of%20Pediatrics%2C%20School%20of%20Medicine%20and%20Student%20Research%20Committee%2C%20Isfahan%20University%20of%20Medical%20Sciences%2C%20Isfahan%2C%20Iran
3 Endocrine and Metabolism Research Center, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4 Metabolism Research Center, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Thrombotic thrombocytopenic purpura (TTP) secondary to diabetic ketoacidosis has been rarely reported and is considered as a rare complication. If left untreated, this condition could be life threatening with considerable morbidity and mortality. Herein, we report a 6-year-old girl with reduced consciousness and respiratory distress with a history of polydipsia and polyuria in the 2 weeks before hospitalization. The patient was initially diagnosed as diabetic ketoacidosis based on clinical and laboratory findings and treated accordingly. After treatment and during hospitalization although she had gained relative consciousness, she experienced seizure and reduced consciousness again. Considering laboratory and clinical findings and the patient's underlying conditions (thrombocytopenia, renal failure, and high lactate dehydrogenase), TTP was suspected although ADAMTS13 test could not be done. Treatment with plasmapheresis was initiated, and after 48 h, the patient was conscious, and laboratory indices became normal within a few days. The patient was discharged after full recovery. TTP should be considered as a rare complication of diabetic ketoacidosis in patients with thrombocytopenia, renal failure, and reduced consciousness and should be immediately treated.
Keywords
1. |
Khan MR, Maheshwari PK, Haque A. Thrombotic microangiopathic syndrome: A novel complication of diabetic ketoacidosis. Indian Pediatr 2013; 50:697-9. [PUBMED] |
2. |
Patra KP, Scott LK. Diabetic ketoacidosis preceding thrombocytopenia associated multiple organ failure in a child. JOP 2011; 12:40-3. [PUBMED] |
3. | |
4. |
Blombery P, Scully M. Management of thrombotic thrombocytopenic purpura: Current perspectives. J Blood Med 2014; 5:15-23. [PUBMED] |
5. |
Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012; 158:323-35. [PUBMED] |
6. | |
7. |
Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol 2003; 108:175-81. [PUBMED] |
8. |
Greaves M, Pickering C, Knight G, Boulton AJ, Ball J, Ward JD, et al. Changes in the factor VIII complex in diabetic ketoacidosis: Evidence of endothelial cell damage? Diabetologia 1987; 30:160-5. [PUBMED] |
9. |
Darmon M, Azoulay E, Thiery G, Ciroldi M, Galicier L, Parquet N, et al. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med 2006; 34:2127-33. [PUBMED] |